How sustained is 24-hour diffusion-weighted imaging lesion reversal?: Serial magnetic resonance imaging in a patient cohort thrombolyzed within 4.5 hours of stroke onset

Stroke

Volumn 46, Issue 3, 2015, Pages 704-710

  Soize, Sebastien ^a,b   Tisserand, Marie ^b   Charron, Sylvain ^b   Turc, Guillaume ^b   Ben Hassen, Wagih ^b   Labeyrie, Marc Antoine ^c   Legrand, Laurence ^b   Mas, Jean Louis ^b   Pierot, Laurent ^a   Meder, Jean François ^b   Baron, Jean Claude ^b   Oppenheim, Catherine ^b  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b CENTRE HOSPITALIER SAINTE ANNE   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Ischemia; Magnetic resonance imaging; Outcomes assessment; Thrombolytic therapy

Indexed keywords

GLUCOSE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY; TIME TO TREATMENT; BRAIN; COHORT ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; REGISTER; REPRODUCIBILITY; STROKE; TIME; TREATMENT OUTCOME; VERY ELDERLY;

ADMINISTRATION, INTRAVENOUS; AGED; AGED, 80 AND OVER; BRAIN; COHORT STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84929294836     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.008322     Document Type: Article

References (30)

1. Hasegawa Y, Fisher M, Latour LL, Dardzinski BJ, Sotak CH. MRI diffusion mapping of reversible and irreversible ischemic injury in focal brain ischemia. Neurology. 1994;44:1484-1490.
2. Davis D, Ulatowski J, Eleff S, Izuta M, Mori S, Shungu D, et al. Rapid monitoring of changes in water diffusion coefficients during reversible ischemia in cat and rat brain. Magn Reson Med. 1994;31:454-460.
3. Li F, Liu KF, Silva MD, Omae T, Sotak CH, Fenstermacher JD, et al. Transient and permanent resolution of ischemic lesions on diffusionweighted imaging after brief periods of focal ischemia in rats: correlation with histopathology. Stroke. 2000;31:946-954.
4. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000;47:462-469.
5. Fiehler J, Foth M, Kucinski T, Knab R, Von Bezold M, Weiller C, et al. Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke. 2002;33:79-86.
6. Labeyrie MA, Turc G, Hess A, Hervo P, Mas JL, Meder JF, et al. Diffusion lesion reversal after thrombolysis: a MR correlate of early neurological improvement. Stroke. 2012;43:2986-2991. doi: 10.1161/STROKEAHA.112.661009.
7. Olivot JM, Mlynash M, Thijs VN, Purushotham A, Kemp S, Lansberg MG, et al. Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR. Stroke. 2009;40:1692-1697. doi: 10.1161/STROKEAHA.108.538082.
8. Luby M, Warach SJ, Nadareishvili Z, Merino JG. Immediate changes in stroke lesion volumes post thrombolysis predict clinical outcome. Stroke. 2014;45:3275-3279. doi: 10.1161/STROKEAHA.114.006082.
9. Inoue M, Mlynash M, Christensen S, Wheeler HM, Straka M, Tipirneni A, et al; DEFUSE 2 Investigators. Early diffusion-weighted imaging reversal after endovascular reperfusion is typically transient in patients imaged 3 to 6 hours after onset. Stroke. 2014;45:1024-1028. doi: 10.1161/STROKEAHA.113.002135.
10. Minematsu K, Li L, Sotak CH, Davis MA, Fisher M. Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke. 1992;23:1304-1310, discussion 1310.
11. Mintorovitch J, Moseley ME, Chileuitt L, Shimizu H, Cohen Y, Weinstein PR. Comparison of diffusion- and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn Reson Med. 1991;18:39-50.
12. Pierpaoli C, Alger JR, Righini A, Mattiello J, Dickerson R, Des Pres D, et al. High temporal resolution diffusion MRI of global cerebral ischemia and reperfusion. J Cereb Blood Flow Metab. 1996;16:892-905. doi: 10.1097/00004647-199609000-00013.
13. Ringer TM, Neumann-Haefelin T, Sobel RA, Moseley ME, Yenari MA. Reversal of early diffusion-weighted magnetic resonance imaging abnormalities does not necessarily reflect tissue salvage in experimental cerebral ischemia. Stroke. 2001;32:2362-2369.
14. Kohno K, Hoehn-Berlage M, Mies G, Back T, Hossmann KA. Relationship between diffusion-weighted MR images, cerebral blood flow, and energy state in experimental brain infarction. Magn Reson Imaging. 1995;13:73-80.
15. Albach FN, Brunecker P, Usnich T, Villringer K, Ebinger M, Fiebach JB, et al. Complete early reversal of diffusion-weighted imaging hyperintensities after ischemic stroke is mainly limited to small embolic lesions. Stroke. 2013;44:1043-1048. doi: 10.1161/STROKEAHA.111.676346.
16. An H, Ford AL, Vo K, Powers WJ, Lee JM, Lin W. Signal evolution and infarction risk for apparent diffusion coefficient lesions in acute ischemic stroke are both time- and perfusion-dependent. Stroke. 2011;42:1276-1281. doi: 10.1161/STROKEAHA.110.610501.
17. Loh PS, Butcher KS, Parsons MW, MacGregor L, Desmond PM, Tress BM, et al. Apparent diffusion coefficient thresholds do not predict the response to acute stroke thrombolysis. Stroke. 2005;36:2626-2631. doi: 10.1161/01. STR.0000189688.95557.2b.
18. Sakamoto Y, Kimura K, Shibazaki K, Inoue T, Uemura J, Aoki J, et al. Early ischaemic diffusion lesion reduction in patients treated with intravenous tissue plasminogen activator: infrequent, but significantly associated with recanalization. Int J Stroke. 2013;8:321-326. doi: 10.1111/j.1747-4949.2012.00902.x.
19. Chemmanam T, Campbell BC, Christensen S, Nagakane Y, Desmond PM, Bladin CF, et al; EPITHET Investigators. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch. Neurology. 2010;75:1040-1047. doi: 10.1212/WNL.0b013e3181f39ab6.
20. Kidwell CS, Saver JL, Starkman S, Duckwiler G, Jahan R, Vespa P, et al. Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol. 2002;52:698-703. doi: 10.1002/ana.10380.
21. Kharitonova T, Mikulik R, Roine RO, Soinne L, Ahmed N, Wahlgren N; Safe Implementation of Thrombolysis in Stroke Investigators. Association of early National Institutes of Health Stroke Scale improvement with vessel recanalization and functional outcome after intravenous thrombolysis in ischemic stroke. Stroke. 2011;42:1638-1643. doi: 10.1161/STROKEAHA.110.606194.
22. Apoil M, Turc G, Tisserand M, Calvet D, Naggara O, Domigo V, et al. Clinical and magnetic resonance imaging predictors of very early neurological response to intravenous thrombolysis in patients with middle cerebral artery occlusion. J Am Heart Assoc. 2013;2:e000511. doi: 10.1161/JAHA.113.000511.
23. Petkova M, Rodrigo S, Lamy C, Oppenheim G, Touzé E, Mas JL, et al. MR imaging helps predict time from symptom onset in patients with acute stroke: implications for patients with unknown onset time. Radiology. 2010;257:782-792. doi: 10.1148/radiol.10100461.
24. Tisserand M, Malherbe C, Turc G, Legrand L, Edjlali M, Labeyrie MA, et al. Is white matter more prone to diffusion lesion reversal after thrombolysis? Stroke. 2014;45:1167-1169. doi: 10.1161/STROKEAHA.113.004000.
25. Henninger N, Sicard KM, Fisher M. Spectacular shrinking deficit: insights from multimodal magnetic resonance imaging after embolic middle cerebral artery occlusion in Sprague-Dawley rats. J Cereb Blood Flow Metab. 2007;27:1756-1763. doi: 10.1038/sj.jcbfm.9600477.
26. Fiehler J, Knudsen K, Kucinski T, Kidwell CS, Alger JR, Thomalla G, et al. Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke. 2004;35:514-519. doi: 10.1161/01. STR.0000114873.28023. C2.
27. Olivot JM, Mlynash M, Thijs VN, Purushotham A, Kemp S, Lansberg MG, et al. Geography, structure, and evolution of diffusion and perfusion lesions in Diffusion and perfusion imaging Evaluation For Understanding Stroke Evolution (DEFUSE). Stroke. 2009;40:3245-3251. doi: 10.1161/STROKEAHA.109.558635.
28. Campbell BC, Davis SM, Donnan GA. How much diffusion lesion reversal occurs after treatment within three-hours of stroke onset? Int J Stroke. 2013;8:329-330. doi: 10.1111/ijs.12101.
29. Furlan M, Marchal G, Viader F, Derlon JM, Baron JC. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol. 1996;40:216-226. doi: 10.1002/ana.410400213.
30. Baron JC, Yamauchi H, Fujioka M, Endres M. Selective neuronal loss in ischemic stroke and cerebrovascular disease. J Cereb Blood Flow Metab. 2014;34:2-18. doi: 10.1038/jcbfm.2013.188.